CytomX Therapeutics
CTMX
CTMX
119 hedge funds and large institutions have $637M invested in CytomX Therapeutics in 2017 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 47 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
23% more funds holding
Funds holding: 97 → 119 (+22)
12.74% more ownership
Funds ownership: 65.75% → 78.49% (+13%)
58% less call options, than puts
Call options by funds: $21K | Put options by funds: $50K
Holders
119
Holding in Top 10
2
Calls
$21K
Puts
$50K
Top Buyers
| 1 | +$23.2M | |
| 2 | +$12.4M | |
| 3 | +$12.4M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.02M |
Top Sellers
| 1 | -$23.4M | |
| 2 | -$15.1M | |
| 3 | -$8.18M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$5.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.67M |